TRIB1 overexpression causes resistance to ATRA (all-trans retinoic acid) treatment during acute promyelocytic leukemia in exclusively sensitive myeloid cells expressing the PML/RARA fusion protein by preventing their differentiation through the downregulation of C/EBPα [95]. The gene discussed is TRIB1; the disease is acute promyelocytic leukemia.